Hemostemix Inc News - HEM

Professional-Grade Tools, for Individual Investors.

IIROC Trading Halt - HEM

IIROC Trading Halt - HEM Canada NewsWire VANCOUVER, BC, Jan. 19, 2023 VANCOUVER, BC, Jan. 19, 2023 /CNW/ - The following issues have been halted...

Virtual Conference for Life Sciences Companies Broadcast Live December 16th

Virtual Conference for Life Sciences Companies Broadcast Live December 16th Canada NewsWire NEW YORK, Dec. 14, 2021 Company executives will share...

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT May 10, 2021, Calgary, Alberta -- InvestorsHub...

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list Calgary, Alberta, April 23, 2021-- InvestorsHub...

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates Calgary, Alberta, April...

Hemostemix Announces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets Ltd.

Hemostemix Annonces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets LTD. Calgary...

L'OCRCVM permet la reprise de la négociation - HEM

L'OCRCVM permet la reprise de la négociation - HEM Canada NewsWire VANCOUVER, le 2 mars 2020 VANCOUVER, le 2 mars 2020 /CNW/ - Reprise...

IIROC Trading Resumption - HEM

IIROC Trading Resumption - HEM Canada NewsWire VANCOUVER, March 2, 2020 VANCOUVER, March 2, 2020 /CNW/ - Trading resumes in: Company: Hemostemix...

Hemostemix Announces Corporate Update

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb...

Suspension de la négociation par l'OCRCVM - HEM

Suspension de la négociation par l'OCRCVM - HEM Canada NewsWire VANCOUVER, le 28 févr. 2020 VANCOUVER, le 28 févr. 2020 /CNW/...

IIROC Trading Halt - HEM

IIROC Trading Halt - HEM Canada NewsWire VANCOUVER, Feb. 28, 2020 VANCOUVER, Feb. 28, 2020 /CNW/ - The following issues have been halted by...

Hemostemix Announces Corporate Update

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Feb...

Hemostemix Announces Corporate Update

CALGARY, Alberta, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:...

Hemostemix Announces Financing Update and Secured Convertible Debenture Financing of Up to $2,000,000

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta...

Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update

CALGARY, Alberta, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV:...

JamesMacho 1 year ago

Investors in $HEM are still waiting for any positive financial data to emerge, but so far, it's been a disappointing journey.

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Hemostemix Inc (HEM)

Professional-Grade Tools, for Individual Investors.

HEM News

IIROC Trading Halt - HEM

Virtual Conference for Life Sciences Companies Broadcast Live December 16th

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

Hemostemix Announces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets Ltd.

L'OCRCVM permet la reprise de la négociation - HEM

IIROC Trading Resumption - HEM

Hemostemix Announces Corporate Update

Suspension de la négociation par l'OCRCVM - HEM

IIROC Trading Halt - HEM

Hemostemix Announces Corporate Update

Hemostemix Announces Corporate Update

Hemostemix Announces Financing Update and Secured Convertible Debenture Financing of Up to $2,000,000

Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update

HEM Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Hemostemix Inc (HEM) News

Hemostemix Inc (HEM)

Professional-Grade Tools, for Individual Investors.

HEM News

IIROC Trading Halt - HEM

Virtual Conference for Life Sciences Companies Broadcast Live December 16th

HEMOSTEMIX ANNOUNCES CLOSING OF UNIT PRIVATE PLACEMENT

Hemostemix Announces Completion of Phase II Clinical Trial Subject Follow Up & HMTXF Up-list

Hemostemix Announces a $2,500,000 Lead Order and its Clinical Trial and Litigation Updates

Hemostemix Announces it is Trading on the Frankfurt Stock Exchange and it has Retained HE Capital Markets Ltd.

L'OCRCVM permet la reprise de la négociation - HEM

IIROC Trading Resumption - HEM

Hemostemix Announces Corporate Update

Suspension de la négociation par l'OCRCVM - HEM

IIROC Trading Halt - HEM

Hemostemix Announces Corporate Update

Hemostemix Announces Corporate Update

Hemostemix Announces Financing Update and Secured Convertible Debenture Financing of Up to $2,000,000

Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update

HEM Discussion

Your Recent History